Silo Pharma, Inc. (SILO) analyst actions
Rating and price-target actions on SILO in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the SILO overview →
2 measured SILO analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Silo Pharma Advances PTSD Drug SPC-15 Toward First-in-Human Trial with Key Safety Study Initiated at Frontage Laboratories | Press release | -1.50% | -15.56% | |
| Silo Pharma Initiates Pharmacokinetic and Tolerability Study for SP-26 Targeting Chronic Pain and Fibromyalgia | Press release | -0.17% | -6.55% |
Keep exploring
More SILO: earnings → · SEC filings → · SILO overview →